title: Molecular pathways: environmental estrogens activate nongenomic signaling to developmentally reprogram the epigenome.
abstract: Exposure to environmental xenoestrogens is a major health concern because of the ability of these compounds to perturb estrogen receptor (ER) signaling and act as endocrine disrupting compounds (EDC). Inappropriate exposure to EDCs during development, even at low doses, can predispose individuals to an increased lifetime risk of disease, including cancer. Recent data indicate that perinatal exposure to EDCs increases cancer risk by (re)programming the epigenome via alterations in DNA and histone methylation. We and others have begun to dissect the mechanisms by which xenoestrogens disrupt the epigenetic machinery to reprogram the epigenome and induce developmental reprogramming. Our studies revealed that xenoestrogens induce nongenomic ER signaling to activate PI3K/AKT, resulting in AKT phosphorylation and inactivation of the histone methyltransferase EZH2, thus providing a direct link to disruption of the epigenome. Other epigenetic "readers, writers, and erasers" may also be targeted by nongenomic signaling, suggesting this is a central mechanism by which xenoestrogens and other EDCs disrupt the epigenome to induce developmental reprogramming. Elucidating mechanisms of developmental reprogramming of the epigenome is important for understanding how environmental exposures increase cancer risk, and provides a rationale for developing epigenetic interventions that can reverse the effects of environmental exposures to reduce cancer risk.
authors.affiliation: Center for Translational Cancer Research, Institute of Biosciences and Technology, The Texas A&M University System Health Science Center, Houston, Texas 77030, USA. cwalker@ibt.tamhsc.edu
authors.forename: Rebecca Lee Yean
authors.initials: RL
authors.lastname: Wong
authors.forename: Cheryl Lyn
authors.initials: CL
authors.lastname: Walker
mesh_terms: D000818:Animals; D004198:Disease Susceptibility / Q000139:chemically induced; D052244:Endocrine Disruptors / Q000633:toxicity*; D004781:Environmental Exposure; D044127:Epigenesis, Genetic; D004967:Estrogens / Q000633:toxicity*; D015894:Genome, Human; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced / Q000235:genetics; D011960:Receptors, Estrogen / Q000378:metabolism*; D012307:Risk Factors; D015398:Signal Transduction
chemical_list: D052244:Endocrine Disruptors; D004967:Estrogens; D011960:Receptors, Estrogen
references.citation: Nat Rev Cancer. 2012 Jun 14;12(7):479-86
references.pmid: 22695395
references.citation: Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8644-9
references.pmid: 15937110
references.citation: Cell Signal. 2012 Dec;24(12):2369-77
references.pmid: 22906493
references.citation: Curr Opin Cell Biol. 2008 Jun;20(3):316-25
references.pmid: 18440794
references.citation: J Mol Signal. 2009 Apr 28;4:2
references.pmid: 19400946
references.citation: Nature. 2010 Jul 22;466(7305):508-12
references.pmid: 20622854
references.citation: Science. 2005 Oct 14;310(5746):306-10
references.pmid: 16224021
references.citation: Cancer Res. 2001 Aug 15;61(16):5985-91
references.pmid: 11507039
references.citation: Endocrinology. 2004 Dec;145(12):5532-9
references.pmid: 15319357
references.citation: Mol Biol Cell. 2005 Jan;16(1):231-7
references.pmid: 15496458
references.citation: Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20178-83
references.pmid: 22123949
references.citation: Mol Cell Endocrinol. 2007 Aug 15;274(1-2):1-7
references.pmid: 17601655
references.citation: Physiol Rev. 2003 Jul;83(3):965-1016
references.pmid: 12843413
references.citation: Endocrinology. 2006 Jun;147(6 Suppl):S56-69
references.pmid: 16690810
references.citation: J Biol Chem. 2004 Jun 25;279(26):27008-16
references.pmid: 15090535
references.citation: Science. 2001 Aug 10;293(5532):1074-80
references.pmid: 11498575
references.citation: Nature. 2000 Sep 28;407(6803):538-41
references.pmid: 11029009
references.citation: Biochim Biophys Acta. 2011 Apr;1810(4):427-31
references.pmid: 21145940
references.citation: Nat Cell Biol. 2009 Nov;11(11):1376-82
references.pmid: 19783983
references.citation: Steroids. 2007 Feb;72(2):124-34
references.pmid: 17174995
references.citation: Reprod Sci. 2008 Oct;15(8):765-78
references.pmid: 19017814
references.citation: Nat Cell Biol. 2006 Apr;8(4):407-15
references.pmid: 16531993
references.citation: Nat Rev Cancer. 2002 Jul;2(7):489-501
references.pmid: 12094235
references.citation: EMBO J. 2000 Oct 16;19(20):5406-17
references.pmid: 11032808
references.citation: Mol Endocrinol. 2010 May;24(5):993-1006
references.pmid: 20351197
references.citation: Endocrinology. 2005 Mar;146(3):1312-20
references.pmid: 15591142
references.citation: Genes Dev. 2010 Nov 15;24(22):2531-42
references.pmid: 20966048
references.citation: J Biol Chem. 2011 Aug 12;286(32):28511-9
references.pmid: 21659531
references.citation: Mol Cell. 2001 Aug;8(2):269-80
references.pmid: 11545730
references.citation: Immunol Lett. 2003 Mar 3;86(1):57-61
references.pmid: 12600746
references.citation: Environ Health Perspect. 2009 Jul;117(7):1053-8
references.pmid: 19654912
references.citation: Arch Biochem Biophys. 2008 Dec 15;480(2):143-55
references.pmid: 18938131
references.citation: Pharmacol Res. 2011 Nov;64(5):509-16
references.pmid: 21641998
references.citation: J Environ Public Health. 2012;2012:713696
references.pmid: 22991565
references.citation: J Biol Chem. 2007 Aug 3;282(31):22278-88
references.pmid: 17535799
references.citation: Biochem Biophys Res Commun. 2012 Aug 3;424(3):538-43
references.pmid: 22771325
references.citation: Nat Cell Biol. 2011 Jun;13(6):668-75
references.pmid: 21532585
references.citation: Cancer Lett. 2006 Jul 8;238(1):1-14
references.pmid: 16084012
references.citation: Nutr Cancer. 2001;40(2):79-86
references.pmid: 11962259
references.citation: Circ Res. 2000 Nov 24;87(11):E44-52
references.pmid: 11090554
references.citation: Mol Pharmacol. 2005 Oct;68(4):933-41
references.pmid: 16020742
references.citation: PLoS One. 2010 Apr 06;5(4):e10042
references.pmid: 20386606
references.citation: Steroids. 2004 Mar;69(3):181-92
references.pmid: 15072920
references.citation: Nature. 2008 May 29;453(7195):682-6
references.pmid: 18438399
references.citation: EMBO J. 2001 Nov 1;20(21):6050-9
references.pmid: 11689445
references.citation: J Mol Endocrinol. 2007 Jun;38(6):603-18
references.pmid: 17556531
references.citation: Nat Cell Biol. 2007 Nov;9(11):1273-85
references.pmid: 17952062
references.citation: J Steroid Biochem Mol Biol. 2006 Feb;98(2-3):122-32
references.pmid: 16413991
references.citation: Mol Endocrinol. 2002 Oct;16(10):2181-7
references.pmid: 12351684
references.citation: Nucleic Acids Res. 2011 May;39(10):4151-65
references.pmid: 21296759
references.citation: J Biol Chem. 2003 Oct 31;278(44):42992-3000
references.pmid: 12933816
references.citation: Mol Cell Biol. 2007 Jan;27(2):466-80
references.pmid: 17074804
references.citation: Mol Cell. 2007 Jan 12;25(1):1-14
references.pmid: 17218267
references.citation: Cell. 2001 Mar 9;104(5):719-30
references.pmid: 11257226
references.citation: J Biol Chem. 2009 Dec 25;284(52):36167-36174
references.pmid: 19843527
references.citation: Mol Cancer Res. 2012 Apr;10(4):546-57
references.pmid: 22504913
references.citation: J Pharmacol Exp Ther. 2010 Feb;332(2):554-61
references.pmid: 19906781